Pharmacists in Santa Barbara, California


92 Pharmacists found in Santa Barbara
male pharmacist

Dr. Scott Erik Mcleod, PHARMD


Pharmacist
617 Garden St, Santa Barbara, CA 93101
805-884-8440    

female pharmacist

Sharise Michelle Redmond, PHARMD


Pharmacist
400 W Pueblo St, Santa Barbara, CA 93105
909-844-0303    

female pharmacist

Sheila J Neary, RPH


Pharmacist
215 Pesetas Ln, Santa Barbara, CA 93110
805-681-1761     805-681-1768



female pharmacist

Silpa N/a Nunna, PHARMD


Pharmacist
100 W Carrillo St, Santa Barbara, CA 93101
805-302-7189    

male pharmacist

Dr. Spencer Brown, PHARM.D.


Pharmacist
35 S Milpas St, Santa Barbara, CA 93103
805-965-0787    

female pharmacist

Stephanie Anderson, PHARMD


Pharmacist
400 West Pueblo Street - Cottage Healthcare System, Pharmacy Department, Santa Barbara, CA 93105
805-569-8344     805-569-7551

female pharmacist

Stephanie Ferguson, PHARMD


Pharmacist
215 Pesetas Ln, Santa Barbara, CA 93110
805-681-1761     805-681-1768

male pharmacist

Mr. Steven Chung, RPH, PHARM.D


Pharmacist
1282 Coast Village Rd, Santa Barbara, CA 93108
805-565-0897    

male pharmacist

Suraj Dalsania, RPH


Pharmacist
2973 State St, Santa Barbara, CA 93105
805-682-3761     805-682-8349

male pharmacist

Thomas Johnsonbaugh, RPH


Pharmacist
336 N Milpas St, Santa Barbara, CA 93103
805-560-0092     805-396-5736

female pharmacist

Dr. Tiffany Riley, PHARMD


Pharmacist
336 N Milpas St, Santa Barbara, CA 93103
805-560-0092    

female pharmacist

Yih-chen Lin


Pharmacist
100 W Carrillo St, Santa Barbara, CA 93101
805-564-7070    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.